Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials

AIMS/HYPOTHESIS: Observational and mechanistic studies have suggested a possible relationship between treatment with metformin and decreased incidence of cancer in participants with type 2 diabetes. We extracted data for malignancies from the ADOPT (A Diabetes Outcome Progression Trial) and RECORD (...

Descripción completa

Detalles Bibliográficos
Autores principales: Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., Viberti, G.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910882/
https://www.ncbi.nlm.nih.gov/pubmed/20532476
http://dx.doi.org/10.1007/s00125-010-1804-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910882/
https://www.ncbi.nlm.nih.gov/pubmed/20532476
http://dx.doi.org/10.1007/s00125-010-1804-y

Ejemplares similares